These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 24955450)

  • 1. Efficacy and safety of esomeprazole with flupentixol/melitracen in treating gastroesophageal reflux disease patients with emotional disorders.
    Yu YY; Fang DC; Fan LL; Chang H; Wu ZL; Cao Y; Lan CH
    J Gastroenterol Hepatol; 2014 Jun; 29(6):1200-6. PubMed ID: 24955450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical observation of flupentixol and melitracen combined with specific immunotherapy for treatment of allergic rhinitis patients with anxiety and depression].
    Yi ZG; Yang XH; Ren JJ; Peng WH; Liang QL
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Jan; 31(1):34-37. PubMed ID: 29774682
    [No Abstract]   [Full Text] [Related]  

  • 3. Short-Term Symptomatic Relief in Gastroesophageal Reflux Disease: A Comparative Study of Esomeprazole and Vonoprazan.
    Sakurai K; Suda H; Fujie S; Takeichi T; Okuda A; Murao T; Hasuda K; Hirano M; Ito K; Tsuruta K; Hattori M
    Dig Dis Sci; 2019 Mar; 64(3):815-822. PubMed ID: 30415407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The combination therapy with esomeprazole and flupenthixol/melitracen in symptom improvement of erosive gastritis complicated with negative feelings compared with Esomeprazole alone.
    Hu L; Shen L; Li D; Huang M; Xiao X; Chen S
    Cell Mol Biol (Noisy-le-grand); 2020 Jul; 66(5):15-19. PubMed ID: 33040806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical efficacy of 60-mg dexlansoprazole and 40-mg esomeprazole after 24 weeks for the on-demand treatment of gastroesophageal reflux disease grades A and B: a prospective randomized trial.
    Chiang HH; Wu DC; Hsu PI; Kuo CH; Tai WC; Yang SC; Wu KL; Yao CC; Tsai CE; Liang CM; Wang YK; Wang JW; Huang CF; Chuah SK;
    Drug Des Devel Ther; 2019; 13():1347-1356. PubMed ID: 31118571
    [No Abstract]   [Full Text] [Related]  

  • 6. Prevalence of gastroesophageal reflux disease symptoms and effects of esomeprazole on the quality of life related to reflux and dyspepsia in patients on maintenance hemodialysis.
    Namikoshi T; Harada K; Hatta H; Tokura T; Oshiro Y; Nishizaki T; Obata T; Mori M; Fueki T; Fujimoto S; Haruna Y; Kuwabara A; Yorimitsu D; Ihoriya C; Kadoya H; Itano S; Fujimoto Y; Komai N; Sasaki T; Kashihara N
    Clin Exp Nephrol; 2016 Feb; 20(1):134-42. PubMed ID: 26026991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Postprandial Administration of Esomeprazole on Reflux Symptoms in Gastroesophageal Reflux Disease: A Randomized, Controlled Trial.
    Boltin D; Zvidi I; Raskin M; Kayless H; Schmilovitz-Weiss H; Gingold-Belfer R; Niv Y; Dickman R
    Dig Dis; 2018; 36(4):257-263. PubMed ID: 29791895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Laparoscopic antireflux surgery vs esomeprazole treatment for chronic GERD: the LOTUS randomized clinical trial.
    Galmiche JP; Hatlebakk J; Attwood S; Ell C; Fiocca R; Eklund S; Långström G; Lind T; Lundell L;
    JAMA; 2011 May; 305(19):1969-77. PubMed ID: 21586712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and symptom improvement with esomeprazole in adolescents with gastroesophageal reflux disease.
    Gold BD; Gunasekaran T; Tolia V; Wetzler G; Conter H; Traxler B; Illueca M
    J Pediatr Gastroenterol Nutr; 2007 Nov; 45(5):520-9. PubMed ID: 18030228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Once-daily pantoprazole 40 mg and esomeprazole 40 mg have equivalent overall efficacy in relieving GERD-related symptoms.
    Scholten T; Gatz G; Hole U
    Aliment Pharmacol Ther; 2003 Sep; 18(6):587-94. PubMed ID: 12969085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomised clinical trial: daily pantoprazole magnesium 40 mg vs. esomeprazole 40 mg for gastro-oesophageal reflux disease, assessed by endoscopy and symptoms.
    Moraes-Filho JP; Pedroso M; Quigley EM;
    Aliment Pharmacol Ther; 2014 Jan; 39(1):47-56. PubMed ID: 24299323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of non-erosive reflux disease with a proton pump inhibitor in Chinese patients: a randomized controlled trial.
    Tan VP; Wong WM; Cheung TK; Lai KC; Hung IF; Chan P; Pang R; Wong BC
    J Gastroenterol; 2011 Jul; 46(7):906-12. PubMed ID: 21538030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tegaserod for dyspepsia and reflux symptoms in patients with chronic constipation: an exploratory open-label study.
    Zeng J; Zuo XL; Li YQ; Wei W; Lv GP
    Eur J Clin Pharmacol; 2007 Jun; 63(6):529-36. PubMed ID: 17468863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of clinician-patient communication on compliance with flupentixol-melitracen in functional dyspepsia patients.
    Yan XJ; Li WT; Chen X; Wang EM; Liu Q; Qiu HY; Cao ZJ; Chen SL
    World J Gastroenterol; 2015 Apr; 21(15):4652-9. PubMed ID: 25914475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Esomeprazole regimens for reflux symptoms in Chinese patients with chronic gastritis.
    Sun J; Yuan YZ; Hou XH; Zou DW; Lu B; Chen MH; Liu F; Wu KC; Zou XP; Li YQ; Zhou LY
    World J Gastroenterol; 2015 Jun; 21(22):6965-73. PubMed ID: 26078574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of once-daily esomeprazole for the treatment of gastroesophageal reflux disease in neonatal patients.
    Davidson G; Wenzl TG; Thomson M; Omari T; Barker P; Lundborg P; Illueca M
    J Pediatr; 2013 Sep; 163(3):692-8.e1-2. PubMed ID: 23800403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 40 mg pantoprazole and 40 mg esomeprazole are equivalent in the healing of esophageal lesions and relief from gastroesophageal reflux disease-related symptoms.
    Gillessen A; Beil W; Modlin IM; Gatz G; Hole U
    J Clin Gastroenterol; 2004 Apr; 38(4):332-40. PubMed ID: 15087692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and Tolerability of Esomeprazole in Children With Gastroesophageal Reflux Disease.
    Gilger MA; Tolia V; Vandenplas Y; Youssef NN; Traxler B; Illueca M
    J Pediatr Gastroenterol Nutr; 2015 Jul; 60 Suppl 1():S16-23. PubMed ID: 26422093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Observation of Flupentixol and melitracen on curative effect of sudden deafness patients with anxiety and depression in different stages].
    Zhang T; Yu GD
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 May; 32(9):643-646. PubMed ID: 29771077
    [No Abstract]   [Full Text] [Related]  

  • 20. The new proton pump inhibitor esomeprazole is effective as a maintenance therapy in GERD patients with healed erosive oesophagitis: a 6-month, randomized, double-blind, placebo-controlled study of efficacy and safety.
    Vakil NB; Shaker R; Johnson DA; Kovacs T; Baerg RD; Hwang C; D'Amico D; Hamelin B
    Aliment Pharmacol Ther; 2001 Jul; 15(7):927-35. PubMed ID: 11421866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.